Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells.

Huang, Ming-Bo; Gao, Zhao; Xia, Meng; Zhao, Xiaoqing; Fan, Xiaoyuan; Lin, Shijie; Zhang, Lifeng; Huang, Li; Wei, Ailing; Zhou, Hu; Wu, Jennifer Y; Roth, William W; Bond, Vincent C; Leng, Jing

Huang, Ming-Bo; Gao, Zhao; Xia, Meng; Zhao, Xiaoqing; Fan, Xiaoyuan; Lin, Shijie; Zhang, Lifeng; Huang, Li; Wei, Ailing; Zhou, Hu; Wu, Jennifer Y; Roth, William W; Bond, Vincent C; Leng, Jing.

Afiliación

Huang MB; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine Atlanta, Georgia 30310, USA.
Gao Z; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Xia M; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Zhao X; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Fan X; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Lin S; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Zhang L; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Huang L; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Wei A; The First Affiliated Hospital of Guangxi University of Chinese Medicine Nanning 530023, Guangxi, China.
Zhou H; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.
Wu JY; Columbia College, Columbia University New York, NY 10027, USA.
Roth WW; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine Atlanta, Georgia 30310, USA.
Bond VC; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine Atlanta, Georgia 30310, USA.
Leng J; Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Guangxi University of Chinese Medicine Nanning 530200, Guangxi, China.

Int J Physiol Pathophysiol Pharmacol ; 14(2): 90-113, 2022.

Article en En | MEDLINE | ID: mdl-35619665

Palabras clave

Improved-Aitongxiao prescription (I-ATXP); apoptosis; cell cycle; exosomes; hepatocellular carcinoma (HCC) cell lines; invasion; migration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Physiol Pathophysiol Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google